Pasqal Holding SA (NASDAQ: PSQL) reported revenue of €4.9 million for the first half of 2026, marking a 14% year-over-year increase. The neutral-atom quantum computing firm saw QPU-related services revenue grow 34% to €3.9 million, driven by expanding commercial partnerships and customer deployments.

Despite top-line growth, the company recorded an operating loss of €59.2 million, a significant widening from €19.8 million in the comparable period last year. This expansion was primarily attributed to €37.5 million in share-based payments and one-time charges related to its recent business combination and listing process.

Financial Performance Overview

The company’s financial highlights for the six months ended June 30, 2026, reflect a phase of heavy investment in talent and infrastructure alongside commercial scaling. Booked and awarded business stood at €70.4 million as of June 30, 2026, providing visibility into future revenue conversion.

Share-based payment charges amounted to €27.3 million in H1 2026, compared to just €1.0 million in H1 2025. Additionally, one-time transaction-related expenses incurred during the completion of the business combination with Bleichroeder Acquisition Corp. II totaled €10.2 million. These non-recurring and non-cash items significantly impacted the bottom line, masking underlying operational trends.

Balance Sheet and Liquidity Position

Pasqal maintained a strong liquidity position, reporting cash and cash equivalents of €110.8 million as of June 30, 2026. Following the successful business combination and related financing transactions completed in August 2026, the company’s cash position rose to approximately €312.9 million as of August 27, 2026. This substantial capital infusion is intended to fund continued growth and technology development without immediate dilution or debt reliance.

Total assets grew to €234.8 million from €187.8 million at the end of 2025, driven largely by the increase in cash reserves and equity from the listing process. Total equity turned positive at €129.1 million, reversing a deficit position from the previous period.

What the Numbers Show

A divergence exists between the modest 14% overall revenue growth and the robust 34% growth in QPU-related services. This suggests that while total bookings are rising, the mix is shifting heavily toward core quantum processing unit services, which now constitute roughly 80% of total revenue (€3.9 million out of €4.9 million). The sharp rise in employee salaries and benefit expenses to €41.6 million (from €15.4 million) indicates aggressive hiring ahead of anticipated demand, creating a temporary drag on margins that may normalize as revenue scales.

Strategic and Operational Milestones

During the reporting period, Pasqal advanced several key technological and commercial initiatives:

• Technological Scaling: The company demonstrated defect-free registers of 1,024 atoms, doubling its previous record, and extended atom lifetimes approximately 40-fold through a redesigned cryogenic platform.
• Commercial Partnerships: Pasqal launched Saudi Arabia’s first quantum computer and the Middle East’s first commercial Quantum Computing as a Service platform with Saudi Aramco. It also advanced strategic partnerships with Crédit Agricole CIB for financial applications and NVIDIA for hybrid quantum-classical computing.
• Research Validation: Experimental validation of quantum simulation was achieved using up to 256 atoms on Orion Beta QPUs, with results cited by Nature in March 2026.
• Leadership: Stéphane Rougeot was appointed Chief Financial Officer to lead the global finance organization.

The company remains focused on leveraging its capital-efficient neutral-atom architecture to deploy systems in conventional data centers, aiming to lower total cost of ownership for enterprise customers across energy, financial services, and advanced materials.

Pasqal Holding (NASDAQ: PSQL) shares fell 14.86% to $16.27 in premarket trading on Monday, following the company's debut on the Nasdaq exchange on August 28, 2026. The listing marks the completion of its business combination with Bleichroeder Acquisition Corp. II.

The transaction provides Pasqal with approximately $360 million in cash at closing. Shareholders approved the deal and related proposals on August 25, 2026. The capital infusion aims to strengthen the company's financial base for global quantum computing deployments.

Capital Allocation Strategy

Pasqal plans to deploy the proceeds across several strategic initiatives:

• Expanding quantum processing unit (QPU) manufacturing and deployment
• Advancing its fault-tolerant quantum computing roadmap
• Broadening access to its cloud and software platform
• Strengthening integration with classical high-performance computing infrastructure
• Expanding global commercial operations

Operational Footprint

Co-founded by Nobel Prize-winning physicist Alain Aspect, Pasqal currently has seven QPUs deployed globally, with three additional units in production. Its technology utilizes neutral atoms arranged in 2D and 3D lattices to offer a scalable, energy-efficient approach to quantum computing.

The company’s QPUs support more than 25 commercial and research applications across sectors including energy, financial services, and materials science. These systems are accessible via cloud platforms spanning North America, Europe, the Middle East, and Asia.

Market Reaction

Trading under tickers PSQL and PSQLW, the stock entered price discovery amidst post-combination volatility. Technical levels show a 52-week range between $20.10 (August high) and $13.08 (August low). The current price action places the stock near the middle of this band after failing to hold recent strength.

What the Numbers Show

The significant premarket decline of 14.86% contrasts with the substantial $360 million cash raise, suggesting immediate market skepticism regarding valuation or supply dynamics following the SPAC merger. While the cash position provides a strong buffer for capital-intensive QPU manufacturing, the sharp sell-off indicates investors are pricing in potential dilution or execution risks associated with the transition to public markets.